Reconsideration of Antinucleocapsid IgG Antibody as a Marker of SARS-CoV-2 Infection Postvaccination for Mild COVID-19 Patients.
Open Forum Infect Dis
; 10(1): ofac677, 2023 Jan.
Article
in English
| MEDLINE | ID: covidwho-2190085
ABSTRACT
Antinucleocapsid (anti-N) immunoglobulin G antibody responses were lower in plasma and oral fluid after severe acute respiratory syndrome coronavirus 2 infection in vaccinated patients compared with patients infected before vaccination or infected without vaccination. This raises questions about the long-term use of anti-N antibodies as a marker for natural infection for surveillance.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Topics:
Vaccines
Language:
English
Journal:
Open Forum Infect Dis
Year:
2023
Document Type:
Article
Affiliation country:
Ofid
Similar
MEDLINE
...
LILACS
LIS